While it’s healthy to see market breadth improving as investors rotate their money out of tech names, it’s important to watch ...

U.S. stocks edged lower Monday afternoon as investors awaited a batch of economic data due later this week, according to José ...

The company is investing $1 billion in OpenAI and will license its characters for use in ChatGPT and video ...

The software maker's revenue and operating income missed expectations, fueling concerns over its ability to capitalize on the artificial-int ...

・Adaptive Biotechnologies (ADPT) is a commercial-stage biotech with strong technical momentum. ・Shares are up 250% in the past year and just hit a new three-year high. ・ADPT maintains a 100% “Buy” ...